A retrospective analysis of Hickman line-associated complications in patients with solid tumours undergoing infusional chemotherapy

Acta Oncologica

Volumn 38, Issue 8, 1999, Pages 1103-1107

  O'Neill, Vincent J ^a,b   Evans, T R Jeffrey ^a   Preston, Janice ^a   Moss, John ^a   Kaye, Stanley Bernard ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL;

ADULT; AGED; ARTERY INJURY; ARTICLE; BREAST CANCER; CENTRAL VENOUS CATHETER; COLON CANCER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PANCREAS CANCER; PNEUMOTHORAX; PRIORITY JOURNAL; RISK ASSESSMENT; SEPSIS; STOMACH CANCER; VASCULAR ACCESS; VEIN THROMBOSIS;

EID: 0033451620     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418699432437     Document Type: Article

References (21)

1. Lemas HM. Reduction of 5-fluorouracil toxicity in man with retention of anticancer effects by prolonged intravenous administration in 5% dextrose. Cancer Chemother 1960; 8: 97-101.
2. Collins JM, Dedrick RL, King FG, Speyer JL, Myers CE. Non-linear pharmacokinetic models for 5-fluorouracil in man: intravenous and intraperitoneal routes. Clin Pharmacol Ther 1980; 28: 235-46.
3. Liver Infusion Meta-analysis Group. Portal vein chemotherapy for colorectal cancer: a meta-analysis of 4000 patients in 10 studies. J Natl Cancer Inst 1997; 8: 497-505.
4. Vokes EE, Schilksky RL, Choi KE. A randomised study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer. Cancer 1989; 63: 30-6.
5. Jones AL, Smith IE, O'Brien ME, et al. Phase II study of continuous infusion fluorouracil with epirubicin and cisplatinum in patients with metastatic and locally advanced breast cancer: an active new regimen. J Clin Oncol 1994; 12: 1259-65.
6. Hickman RO, Buckner CD, Clift RA. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynaecol Obstet 1979; 148: 871-5.
7. Raad I, Davis S, Becker M, et al. Low infection rate and long durability of non-tunnelled silastic catheters. Arch Int Med 1993; 153: 1791-6.
8. Adam A. Insertion of long term venous catheters: time for a new look. Br Med J 1995; 311: 341-2.
9. Cockburn JF, Eynon CA, Virji N. Insertion of Hickman central venous catheters by using angiographic techniques in patients with haematologic disorders. Am J Radiol 1992; 159: 121-4.
10. Levine M, Hirsh J, Gent M. Double-blind randomised trial of very low dose warfarin for prevention of thrombo-embolism in Stage IV breast cancer. Lancet 1994; 343: 886-9.
11. Bern MM, Lokich JJ, Wallach SR. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomised prospective trial. Ann Int Med 1990; 112: 423-8.
12. Evans TRJ, Lofts FJ, Mansi JL, Glees JP, Dalgeish AG, Knight MJ. A phase two study of continuous-infusion 5- fluorouracil with cisplatin and epirubicin in inoperable breast cancer. Br J Cancer 1996; 73: 1260-4.
13. Lokich JJ, Bothe A, Benotti PN. Complications and management of implanted venous access catheters. J Clin Oncol 1985; 3: 710-7.
14. Rigg A, Hughes P, Lopez A. Right phrenic nerve palsy as a complication of indwelling central venous catheters. Thorax 1997; 52: 831-3.
15. Manheimer F, Aranda CD, Smith RL. Necrotising pneumonitis caused by 5-fluorouracil infusion. Cancer 1992; 70: 554-6.
16. Page AC, Evans RA, Kaczmarski R. The insertion of chronic indwelling central venous catheters (Hickman lines) in interventional radiology suites. Clin Radiol 41 1990; 41: 105-9.
17. Mueller BU, Skelton J, Callander DPE, et al. A prospective randomised trial comparing the infectious and noninfectious complications of an externalised catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol 1992; 12: 1943-8.
18. Harrington KJ, Kelly SA, Pandha JE, Jackson JE, Hollyer JS, McKenzie CG. An audit of Hickman catheters use in patients with solid tumours. Clin Oncol 1994; 6: 288-93.
19. Howell PB, Walters PE, Donowitz GR, Farr BM. Risk factors for infection of adult patients with cancer who have tunnelled venous catheters. Cancer 1994; 6: 1367-75.
20. Bisset D, Kaye SB, Baxter G, Moss J. Successful thrombolysis of SVC thrombosis associated with Hickman lines and continuous infusion chemotherapy. Clin Oncol 1996; 8: 247-9.
21. Nightingale CE, Norman A, Cunningham D, Young J, Webb A, Filshie J. A prospective analysis of 949 long term central venous access catheters for ambulatory chemotherapy in patients with gastrointestinal malignancy. Eur J Cancer 1997; 3: 398-403.